Particle Sciences Inc

Activities: Drug Delivery Research & Development Pharmaceutical

Trending Articles

  1. Knowledge and adaptability drive successful pharmaceutical outsourcing partnerships Third-party contract manufacturers and packers play an increasingly prominent role in the pharmaceutical sector, helping companies to both navigate the complexities of the...
  2. dsm-firmenich showcases excipient and sustainability solutions at CPHI Milan The company will present its range of solutions designed to boost patient compliance, while also exhibiting its pharma-grade CBD ingredient
  3. Roche's cancer immunotherapy Tecentriq Hybreza bags FDA approval The drug first and only subcutaneous PD-(L)1 inhibitor available for patients with certain types of lung, skin, liver and soft tissue cancers
  4. Reducing a chemical manufacturing plant’s energy demand The industrial sector has historically associated energy efficiency with making incremental improvements to thermal utility systems. Typical gains and carbon dioxide reductions...
  5. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

Manufacturing

Particle Sciences expands controlled substance capabilities

The Drug Enforcement Administration has granted authorisation to the CDMO for Schedule I substances

Particle Sciences invests in commercialisation expertise

Drug Delivery

Companies partner to improve vaginal rings

Particle Sciences and Encube Ethicals have announced partnership to develop new drug delivery vaginal rings aimed at improving drug effectiveness and patient compliance
Manufacturing

Particle Sciences strengthens nanomilling offering

New API screening programme is available from the CDMO
Media

Looking back on 2018 and making predictions for 2019

As the global pharmaceutical industry transitions from the knowns of 2018 into the unknowns of 2019, Dr Kevin Robinson caught up with some of the key players in the market to assess the year that was and the 12 months to come in terms of upcoming trends and developments
Manufacturing

Particle Sciences announces milestone in Diazepam-based nasal delivery formulation

VALTOCO, a proprietary nasal delivery formulation, has been submitted as a New Drug Application (NDA) to the FDA in the US
Recruitment

Particle Sciences appoints president
Subscribe now